Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tandem Mass Spectrometry | 12 | 2024 | 241 | 1.350 |
Why?
|
| Chromatography, High Pressure Liquid | 9 | 2021 | 465 | 0.500 |
Why?
|
| Chromatography, Liquid | 6 | 2023 | 182 | 0.380 |
Why?
|
| Reproducibility of Results | 12 | 2024 | 1081 | 0.350 |
Why?
|
| Rats | 15 | 2024 | 3735 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2024 | 1766 | 0.290 |
Why?
|
| Griseofulvin | 1 | 2024 | 4 | 0.210 |
Why?
|
| Plasma | 1 | 2022 | 38 | 0.180 |
Why?
|
| Animals | 16 | 2024 | 16992 | 0.170 |
Why?
|
| Weightlessness | 1 | 2021 | 27 | 0.170 |
Why?
|
| Nicotinic Acids | 2 | 2013 | 10 | 0.170 |
Why?
|
| Aminopyridines | 1 | 2020 | 26 | 0.160 |
Why?
|
| Oxyquinoline | 1 | 2020 | 6 | 0.160 |
Why?
|
| Tongue | 1 | 2019 | 16 | 0.160 |
Why?
|
| Mycophenolic Acid | 1 | 2019 | 16 | 0.160 |
Why?
|
| Communicable Diseases | 1 | 2020 | 47 | 0.150 |
Why?
|
| Chloroquinolinols | 1 | 2018 | 4 | 0.150 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 458 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 432 | 0.130 |
Why?
|
| Serum | 1 | 2016 | 17 | 0.130 |
Why?
|
| Mannose | 1 | 2016 | 32 | 0.130 |
Why?
|
| Linear Models | 4 | 2019 | 317 | 0.120 |
Why?
|
| Indoles | 1 | 2016 | 187 | 0.110 |
Why?
|
| Proline | 1 | 2014 | 40 | 0.110 |
Why?
|
| Drug Stability | 4 | 2018 | 129 | 0.100 |
Why?
|
| Sensitivity and Specificity | 3 | 2023 | 611 | 0.100 |
Why?
|
| Esophageal Neoplasms | 1 | 2014 | 140 | 0.100 |
Why?
|
| Male | 12 | 2024 | 23409 | 0.090 |
Why?
|
| Chromans | 1 | 2012 | 16 | 0.090 |
Why?
|
| Antipyrine | 1 | 2012 | 4 | 0.090 |
Why?
|
| Hindlimb Suspension | 1 | 2012 | 16 | 0.090 |
Why?
|
| Menthol | 1 | 2012 | 23 | 0.090 |
Why?
|
| Vitamin E | 1 | 2012 | 62 | 0.090 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2012 | 53 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 146 | 0.080 |
Why?
|
| Administration, Oral | 2 | 2021 | 260 | 0.080 |
Why?
|
| Tissue Distribution | 2 | 2020 | 240 | 0.080 |
Why?
|
| Nicotine | 1 | 2012 | 302 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2024 | 140 | 0.070 |
Why?
|
| alpha-Tocopherol | 1 | 2008 | 27 | 0.070 |
Why?
|
| Vitamin A | 1 | 2008 | 86 | 0.070 |
Why?
|
| Vitamins | 1 | 2008 | 81 | 0.070 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2008 | 89 | 0.070 |
Why?
|
| Neoplasms | 1 | 2016 | 1377 | 0.060 |
Why?
|
| Sulfites | 1 | 2023 | 13 | 0.050 |
Why?
|
| Half-Life | 2 | 2013 | 63 | 0.050 |
Why?
|
| Magnesium Hydroxide | 1 | 2021 | 2 | 0.040 |
Why?
|
| Antacids | 1 | 2021 | 3 | 0.040 |
Why?
|
| Antidiarrheals | 1 | 2021 | 4 | 0.040 |
Why?
|
| Aluminum Hydroxide | 1 | 2021 | 8 | 0.040 |
Why?
|
| Salicylates | 1 | 2021 | 9 | 0.040 |
Why?
|
| Bismuth | 1 | 2021 | 6 | 0.040 |
Why?
|
| Weightlessness Simulation | 1 | 2021 | 26 | 0.040 |
Why?
|
| Biological Availability | 1 | 2021 | 116 | 0.040 |
Why?
|
| Hydrazones | 1 | 2020 | 11 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2021 | 104 | 0.040 |
Why?
|
| Organometallic Compounds | 1 | 2021 | 71 | 0.040 |
Why?
|
| Protein Binding | 1 | 2024 | 1082 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2021 | 150 | 0.040 |
Why?
|
| Chemistry, Physical | 1 | 2020 | 50 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 65 | 0.040 |
Why?
|
| Mice | 2 | 2023 | 6644 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2020 | 229 | 0.040 |
Why?
|
| Heart | 1 | 2020 | 184 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2020 | 570 | 0.030 |
Why?
|
| Kidney | 1 | 2020 | 372 | 0.030 |
Why?
|
| Time Factors | 2 | 2012 | 1857 | 0.030 |
Why?
|
| Humans | 5 | 2020 | 43102 | 0.030 |
Why?
|
| Biotransformation | 1 | 2013 | 69 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2013 | 97 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2012 | 70 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 95 | 0.020 |
Why?
|
| Cotinine | 1 | 2012 | 44 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2012 | 92 | 0.020 |
Why?
|
| Models, Animal | 1 | 2012 | 151 | 0.020 |
Why?
|
| Kinetics | 1 | 2013 | 695 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 449 | 0.020 |
Why?
|
| Liver | 1 | 2012 | 511 | 0.020 |
Why?
|
| gamma-Tocopherol | 1 | 2008 | 19 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 1028 | 0.020 |
Why?
|
| Reference Standards | 1 | 2008 | 55 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2008 | 104 | 0.020 |
Why?
|
| Risk | 1 | 2008 | 287 | 0.020 |
Why?
|
| Female | 3 | 2014 | 24698 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2008 | 587 | 0.020 |
Why?
|
| Temperature | 1 | 2008 | 313 | 0.020 |
Why?
|
| Middle Aged | 2 | 2014 | 12222 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2008 | 1285 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2008 | 469 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 13872 | 0.010 |
Why?
|
| Aged | 1 | 2008 | 8214 | 0.010 |
Why?
|